Radiation recall dermatitis induced by tamoxifen during adjuvant breast cancer treatment
Radiation Oncology Journal
;
: 262-265, 2014.
Article
Dans Anglais
| WPRIM
| ID: wpr-71129
ABSTRACT
Tamoxifen and radiotherapy are used in breast cancer treatment worldwide. Radiation recall dermatitis (RRD), induced by tamoxifen, has been rarely reported. Herein, we report a RRD case induced by tamoxifen. A 47-year-old woman had a right quadrantectomy and an axillary lymph node dissection due to breast cancer. The tumor was staged pT2N0; it was hormone receptor positive, and human epidermal growth factor receptor 2 negative. The patient received adjuvant chemotherapy followed by tamoxifen and radiotherapy. After 22 months of tamoxifen, the patient developed a localized heating sensation, tenderness, edema, and redness at the irradiated area of the right breast. The symptoms improved within 1 week without treatment. Three weeks later, however, the patient developed similar symptoms in the same area of the breast. She continued tamoxifen before and during dermatitis, and symptoms resolved within 1 week.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Radiodermite
/
Radiothérapie
/
Sensation
/
Tamoxifène
/
Région mammaire
/
Tumeurs du sein
/
Traitement médicamenteux adjuvant
/
Dermatite
/
Oedème
/
Récepteurs ErbB
Limites du sujet:
Femelle
/
Humains
langue:
Anglais
Texte intégral:
Radiation Oncology Journal
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS